Antipodean Advisors LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 169 filers reported holding CARDLYTICS INC in Q2 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.

Quarter-by-quarter ownership
Antipodean Advisors LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$330,000
+49.2%
20,000
-42.9%
1.69%
+7.8%
Q2 2023$221,200
+86.2%
35,0000.0%1.57%
+113.5%
Q1 2023$118,825
-72.6%
35,000
-53.3%
0.74%
-49.2%
Q4 2022$433,500
-91.5%
75,000
-86.1%
1.45%
-88.9%
Q3 2022$5,080,000
-64.4%
540,400
-15.4%
13.00%
-44.0%
Q2 2022$14,252,000
-59.4%
638,8000.0%23.22%
-8.7%
Q1 2022$35,121,000
-16.8%
638,8000.0%25.43%
+46.7%
Q4 2021$42,218,000
-21.3%
638,8000.0%17.33%
+14.2%
Q3 2021$53,621,000
-33.9%
638,8000.0%15.18%
-32.0%
Q2 2021$81,083,000
+15.7%
638,8000.0%22.33%
+3.1%
Q1 2021$70,076,000
-25.2%
638,800
-2.6%
21.66%
-17.6%
Q4 2020$93,657,000
+102.3%
656,0000.0%26.30%
+55.3%
Q3 2020$46,294,000
+0.8%
656,0000.0%16.94%
-20.1%
Q2 2020$45,907,000
+100.2%
656,0000.0%21.20%
+0.1%
Q1 2020$22,934,000
-44.4%
656,0000.0%21.17%
-10.3%
Q4 2019$41,236,000
+89.3%
656,000
+0.9%
23.59%
+29.8%
Q3 2019$21,788,000
+489.2%
650,000
+356.6%
18.17%
+304.0%
Q2 2019$3,698,000142,3584.50%
Other shareholders
CARDLYTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Canaan Partners VIII LLC 1,133,141$29,439,00058.62%
Polaris Venture Management Co. V, L.L.C. 2,277,342$59,165,00046.48%
CAS Investment Partners, LLC 2,162,020$56,169,00014.39%
Cannell Capital 626,975$16,289,0004.62%
Antipodean Advisors LLC 142,358$3,698,0004.50%
Shannon River Fund Management LLC 344,230$8,943,0001.42%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 19,048$495,0001.40%
Tygh Capital Management, Inc. 176,237$4,579,0000.78%
Penn Capital Management Company, LLC 263,499$6,846,0000.68%
EAM Global Investors LLC 56,866$1,477,0000.63%
View complete list of CARDLYTICS INC shareholders